| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |